Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1 deadenylase activity
about
The structural basis for the interaction between the CAF1 nuclease and the NOT1 scaffold of the human CCR4-NOT deadenylase complexThe anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complexHeterogeneity and complexity within the nuclease module of the Ccr4-Not complexThe BTG4 and CAF1 complex prevents the spontaneous activation of eggs by deadenylating maternal mRNAs.Insights into the structure and architecture of the CCR4-NOT complexUnderstanding the Phosphorylation Mechanism by Using Quantum Chemical Calculations and Molecular Dynamics Simulations.Multifunctional roles of the mammalian CCR4-NOT complex in physiological phenomena.Candidate tumor suppressor B-cell translocation gene 3 impedes neoplastic progression by suppression of AKT.BTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferationBtg2 is a Negative Regulator of Cardiomyocyte Hypertrophy through a Decrease in Cytosolic RNA.BTG/TOB factors impact deadenylases.The structural basis for deadenylation by the CCR4-NOT complex.BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria.Molecular cloning, sequence analysis, and cadmium stress-rated expression changes of BTG1 in freshwater pearl mussel (Hyriopsis schlegelii).The enzyme activities of Caf1 and Ccr4 are both required for deadenylation by the human Ccr4-Not nuclease module.Structural basis for inhibition of the Tob-CNOT7 interaction by a fragment screening approach.
P2860
Q24298677-3A9F1C46-637E-47B5-ACB1-E7F30433108CQ24306032-43412D34-1E7A-445B-9C46-0955FF4B05ABQ27023667-E370FD38-2F5A-4732-B8CF-FA13351A77C3Q27335982-521319A0-5542-4B60-A69A-0F6146BD967FQ30363357-7FCF7DBF-EFB3-499A-9604-7F51DAA313D8Q30396469-2484F246-186C-4CA5-A363-056AE59C1C5DQ34072690-956D0EBF-6E91-4A26-81CD-5F8F747D4D67Q36347094-E4D50C7F-94A6-47AE-9776-6D13DE9F38F6Q36637122-8F52CB2B-C7E3-4F4C-9775-BB1F0F2BF2D8Q37039869-A3EF783B-E389-43CD-BC2B-ED4645AA00D9Q37455743-32C74162-346B-4859-BEEB-461F87884A9DQ37825827-07D65799-CE2C-47CD-A188-2F9F6B85ED61Q39352908-6886146F-B8E1-4EE5-A518-9CF06CCE3CAEQ41772515-8C3404D5-395C-4052-B043-41DA45FD122DQ43044549-02CE19A1-5EEE-4C95-BB6C-126C9C962FE7Q43159958-E40D904A-C8F8-44E6-BB36-AA99F1EA4816
P2860
Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1 deadenylase activity
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Crystal structures of human BT ...... n of CAF1 deadenylase activity
@ast
Crystal structures of human BT ...... n of CAF1 deadenylase activity
@en
Crystal structures of human BT ...... n of CAF1 deadenylase activity
@en-gb
Crystal structures of human BT ...... n of CAF1 deadenylase activity
@nl
type
label
Crystal structures of human BT ...... n of CAF1 deadenylase activity
@ast
Crystal structures of human BT ...... n of CAF1 deadenylase activity
@en
Crystal structures of human BT ...... n of CAF1 deadenylase activity
@en-gb
Crystal structures of human BT ...... n of CAF1 deadenylase activity
@nl
prefLabel
Crystal structures of human BT ...... n of CAF1 deadenylase activity
@ast
Crystal structures of human BT ...... n of CAF1 deadenylase activity
@en
Crystal structures of human BT ...... n of CAF1 deadenylase activity
@en-gb
Crystal structures of human BT ...... n of CAF1 deadenylase activity
@nl
P2093
P2860
P50
P3181
P356
P1476
Crystal structures of human BT ...... n of CAF1 deadenylase activity
@en
P2093
Masahiro Morita
Tadashi Yamamoto
Toru Suzuki
Xiuna Yang
P2860
P304
P3181
P356
10.1093/NAR/GKN825
P407
P577
2008-12-01T00:00:00Z